Regents of the University of California Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Natera
NTRA
|
+$10.4M |
| 2 |
Cardlytics
CDLX
|
+$1.16M |
| 3 |
FINV
FinVolution Group
FINV
|
+$591K |
| 4 |
Pfizer
PFE
|
+$35.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$481K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.72% |
| 2 | Consumer Staples | 11.49% |
| 3 | Financials | 7.99% |
| 4 | Communication Services | 7.25% |
| 5 | Energy | 5.56% |
Similar funds
Regents of the University of California's Q3 2018 Portfolio in Review
As of Q3 2018, Regents of the University of California held 25 positions worth $51.4M, up 34% from $38.2M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Regents of the University of California deployed $11.7M of net new capital in Q3 2018, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Natera: 430,334 shares worth $10.3M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 45% a quarter earlier, followed by Consumer Staples and Financials.
On the sell side, the most notable exit was Berkshire Hathaway Class B, an estimated $481K sold.
- Regents of the University of California's largest Q3 2018 buy was Natera: 430,334 shares worth $10.3M.
- Regents of the University of California added most to FinVolution Group in Q3 2018, an estimated $591K increase.
- Regents of the University of California fully exited Berkshire Hathaway Class B in Q3 2018, selling an estimated $481K.
- Regents of the University of California's ten largest holdings make up 83% of its $51.4M portfolio in Q3 2018.
- Regents of the University of California opened 2 new positions and closed 1 in Q3 2018.
- Regents of the University of California's portfolio value rose 34% quarter-over-quarter to $51.4M.
Based on Regents of the University of California's 13F filing for Q3 2018, filed 13 Nov 2018.